◀ Back to ANGPT2

ANGPT2 — PGF

Text-mined interactions from Literome

Hayashi et al., Biol Reprod 1999 : As PGF2alpha directly stimulated Ang II release, Ang II may influence the critical period for starting the cascade of functional luteolysis in vivo and might lead to structural luteolysis with ET-1 as a major vasoconstrictor
Aizawa et al., Hypertension 2002 (Hypertension) : In contrast, among these antihypertensive drugs, only losartan was effective in inhibiting the Ang II-induced increase in plasma 8-epi-PGF ( 2alpha ), suggesting that Ang II increases plasma levels of 8-epi-PGF ( 2alpha ) in both a pressor independent and an AT(1) receptor dependent manner
Pan et al., BMC cell biology 2010 (Atherosclerosis) : In growth arrested human VECs and VSMCs, Ang II induced PlGF mRNA expression after 4 hour treatment, and peaked at 24 hours
Vallotton et al., Agents Actions Suppl 1987 : The synthetic ( 1-24 ) atrial natriuretic peptide did not prevent 6-keto-PGF1 alpha release induced by Ang II or AVP in VSMC nor the PGE2 release in cortical tubular cells induced by Ang II
Corriu et al., J Cardiovasc Pharmacol 1995 : We conclude that in both rat resistance and conductance vessels, ANG II induces vasoconstriction through activation of AT1 receptors which are selectively blocked by losartan at nanomolar concentrations and that at micromolar concentrations, losartan may also block the vascular TXA2/PGF2 alpha (TP) receptor